Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HPV Vaccines Receive Narrow Age-Range Endorsement From ACIP Workgroup

Executive Summary

A workgroup of CDC's Advisory Committee on Immunization Practices is recommending routine vaccination with quadrivalent human papillomavirus vaccine for females ages 11 to 12

You may also be interested in...



Gardasil Clears FDA, But Dosing May Pose Administrative Challenges

Administration of Merck's recently approved human papillomavirus vaccine Gardasil at the recommended schedule of zero, two and six months may pose a logistical challenge to vaccinating adolescents

Gardasil Clears FDA, But Dosing May Pose Administrative Challenges

Administration of Merck's recently approved human papillomavirus vaccine Gardasil at the recommended schedule of zero, two and six months may pose a logistical challenge to vaccinating adolescents

Merck Seeks Early Gardasil Male Recommendation, But FDA, CDC Are Wary

Merck's presentation of data on the use of Gardasil in males at FDA's recent Vaccines & Related Biological Products Advisory Committee meeting suggests the firm is positioning the product for a broader recommendation from the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel